Sign up to save your podcasts
Or
Share Dr. Ronald Hirsch of R1RCM discusses new Alzheimer's drug Leqembi with HFMA's Nick Hut
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Dr. Ronald Hirsch of R1RCM discusses new Alzheimer's drug Leqembi with HFMA's Nick Hut
Dr. Ronald Hirsch of R1RCM discusses considerations around a new Alzheimer's drug with Senior Editor Nick Hut.
Mentioned in this episode:
CY 2024 Hospital Outpatient Prospective Payment System (OPPS) Policy Changes: Hospital Price Transparency Proposals (CMS-1786-P) | CMS
NCA - Beta Amyloid Positron Emission Tomography in Dementia and Neurodegenerative Disease (CAG-00431R) - Proposed Decision Memo (cms.gov)
View all episodes
By HFMA
4.2
4141 ratings
Dr. Ronald Hirsch of R1RCM discusses considerations around a new Alzheimer's drug with Senior Editor Nick Hut.
Mentioned in this episode:
CY 2024 Hospital Outpatient Prospective Payment System (OPPS) Policy Changes: Hospital Price Transparency Proposals (CMS-1786-P) | CMS
NCA - Beta Amyloid Positron Emission Tomography in Dementia and Neurodegenerative Disease (CAG-00431R) - Proposed Decision Memo (cms.gov)
More shows like HFMA’s Voices in Healthcare Finance
View all
Planet Money
30,652 Listeners
Marketplace
8,756 Listeners
NPR News Now
14,376 Listeners
WSJ Your Money Briefing
1,718 Listeners
The Hospital Finance Podcast
37 Listeners
The Daily
112,586 Listeners
Up First from NPR
56,435 Listeners
What the Health? From KFF Health News
500 Listeners
Becker’s Healthcare Podcast
190 Listeners
Leadership Without Losing Your Soul: Master Communication & Management Skills To Boost Productivity, Teamwork & Ease Overwhelm
34 Listeners
Tradeoffs
396 Listeners
Consider This from NPR
6,374 Listeners
The Mel Robbins Podcast
20,249 Listeners
Healthcare Blame Game
6 Listeners